Clinical Trials Logo
  1. Home
  2. Cancer, Therapy-Related
  3. NCT06376435

A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia

Cancer, Therapy-Related Clinical Trial

Official title:
A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia

Clinical Trial Summary

The objective of this study was to observe and evaluate the efficacy and safety of hexapopal ethanolamine tablets in the treatment of synchronous/sequential radioimmunoinduced thrombocytopenia in the real world. The subjects of this study were patients with solid malignant tumors who had received radioimmunoinduced thrombocytopenia. This study will retrospectively and prospectively collect real-world data related to investigational drugs, and will observe 500 patients to observe the diagnosis and treatment pattern of radiochemo-induced thrombocytopenia. The study included a screening period (no more than one week) and a treatment period (at least two cycles).Participants meeting protocol inclusion criteria were defined as having platelet values < 100×109/L during radioimmunotherapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06376435
Study type Observational
Source Hebei Medical University Fourth Hospital
Contact
Status Not yet recruiting
Phase
Start date April 20, 2024
Completion date July 1, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT04563013 - Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients N/A
Recruiting NCT05684367 - Exercise to ReGain Stamina and Energy (The EXERGISE Study) N/A
Recruiting NCT05880160 - Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction N/A
Recruiting NCT04151342 - CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Not yet recruiting NCT05465031 - Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Phase 4
Recruiting NCT05797077 - Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA Phase 3
Not yet recruiting NCT03777930 - The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol Phase 4
Recruiting NCT04376229 - Proton Radiation Therapy Registry
Completed NCT06268535 - Identification of Anticancer Drugs Associated With Heart Failure: a WHO Pharmacovigilance Database Analysis
Recruiting NCT05151952 - Proton Therapy Medical Registry